SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-017355
Filing Date
2021-11-04
Accepted
2021-11-04 09:29:20
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp161305_8k.htm   iXBRL 8-K 30090
2 EXHIBIT 99.1 dp161305_ex9901.htm EX-99.1 67587
3 GRAPHIC image_001.jpg GRAPHIC 1883
  Complete submission text file 0000950103-21-017355.txt   285456

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pgen-20211104.xsd EX-101.SCH 3025
5 XBRL LABEL FILE pgen-20211104_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pgen-20211104_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT dp161305_8k_htm.xml XML 3475
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 211378505
SIC: 2834 Pharmaceutical Preparations